| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age ≥ 70 y | 1.989 (1.217–3.251) | 0.006* | 1.909 (1.152–3.162) | 0.012* |
Female sex | 0.857 (0.567–1.296) | 0.466 |  |  |
Stage IV disease | 1.765 (1.015–3.072) | 0.044* | 1.560 (0.879–2.768) | 0.128 |
SPE | 1.823 (1.200–2.768) | 0.005* | 1.341 (0.852–2.110) | 0.205 |
Central or lobar location | 0.775 (0.498–1.206) | 0.258 |  |  |
Central, lobar, or segmental location | 0.902 (0.584–1.393) | 0.643 |  |  |
Multiple | 1.431 (0.760–2.691) | 0.267 |  |  |
Bilateral | 1.142 (0.751–1.738) | 0.535 |  |  |
Combined with DVT | 1.029 (0.684–1.549) | 0.891 |  |  |
ECOG PS > 1 | 2.193 (1.436–3.350) | < 0.001* | 1.702 (1.071–2.705) | 0.025* |
Low BMI | 1.923 (0.779–4.750) | 0.156 |  |  |
Overweight | 0.557 (0.369–0.841) | 0.005* | 0.647 (0.425–0.985) | 0.042* |
Obesity | 0.709 (0.386–1.302) | 0.267 |  |  |
Anticoagulation therapy | 20.698 (0.017–24612.726) | 0.402 |  |  |
Thrombolytic therapy | 1.303 (0.470–3.616) | 0.611 |  |  |
Filter implantation | 0.733 (0.320–1.682) | 0.464 |  |  |
Bleeding event | 0.776 (0.399–1.510) | 0.456 |  |  |